The Cardiometabolic Event of the Year™
18th Annual Cardiometabolic Health Congress
18th Annual Cardiometabolic Health Congress: Social Determinants and Digital Advances in Cardiorenal Metabolic Health
October 18-21, 2023 at the Boston Park Plaza, Boston, MA
The educational design of this activity addresses the needs of US-based healthcare professionals, including cardiologists, endocrinologists, lipidologists, primary care clinicians (PCPs), registered nurses, advanced practice registered nurses, dieticians, pharmacists, and other allied health professionals involved in the management and treatment of cardiometabolic patients.
After completing this activity, the participant should be better able to:
- Discuss the interrelationships among cardiometabolic risk factors and their impact on the development of cardiometabolic diseases, including diabetes, dyslipidemia, hypertension, obesity, kidney disease, and cardiovascular disease
- Interpret the latest evidence and guidelines for the prevention, screening, and treatment of the complex patient with cardiometabolic risk or cardiometabolic disease
- Outline strategies aimed at timely screening and prevention of cardiometabolic disease, including assessment of risk factors and lifestyle modifications
- Develop individualized treatment regimens for patients with cardiometabolic disease based on the efficacy and safety of current and new pharmacotherapies, patient comorbidities and preferences in order to optimize outcomes
- Summarize recent evidence for emerging therapies in order to stay current with the most recent updates in the cardiometabolic field
- Review the role of digital health and technology applications in the prevention and treatment of cardiometabolic risk and disease
JOINT PROVIDERSHIP STATEMENT
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Cardiometabolic Health Congress (CMHC). PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CONTINUING EDUCATION
PACE designates this live activity for a maximum of 17.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NURSING CONTINUING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 17.75 contact hours.
Pharmacotherapy contact hours for Advance Practice Registered Nurses will be designated on your certificate.
PHARMACY CONTINUING EDUCATION
PACE designates this continuing education activity for 17.75 contact hour(s) (1.775 CEUS) of the Accreditation Council for Pharmacy Education.
DIETITIAN CONTINUING EDUCATION
This program offers 17.75 CPEUs for dietitians.
FEE INFORMATION & REFUND/CANCELLATION POLICY
There is a registration fee for participating and receiving CME/CE credit for this educational activity. Registration information can be found here.
HOW TO REQUEST CE CREDIT
Learners may earn up to 17.75 AMA/ACPE/ANCC/CDR credits for attending all general sessions and can earn an additional 4.75 credits for attending all satellite symposia or supported sessions. For CME information on satellite or supported sessions, please visit the CME Symposia section of the mobile app.
An evaluation link will be provided post-meeting to all registered attendees of the Annual meeting. Upon completion of the CME/CE evaluation, attendees will be emailed their certificates within 24 hours (please be sure to check your SPAM folder).
Several email reminders will be sent post-meeting. Please claim your CE credits by completing the evaluation by Tuesday, October 31, 2023.
For Pharmacists: Please allow 2-3 weeks after the deadline for your credit to be submitted to the CPE Monitor.
For questions regarding the evaluation, please contact: [email protected]
Information on planner and faculty disclosures will be available on the mobile app before the meeting.
DISCLOSURE OF CONFLICT OF INTEREST
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.